Found 11 matching trials
Adjuvant Therapy for Potentially Immunotherapy-Responsive Gastric or Gastroesophageal Junction Adenocarcinoma PHASE2 This study evaluates the clinical efficacy and safety benefits of immunothe...
Show More Location
Multiple Locations
Learn More & Join Trial
Neoadjuvant Serplulimab in Combination With Chemotherapy in Locally Advanced Gastric or Gastro-esophageal Junction Cancer PHASE2 evaluate efficacy and safety of neoadjuvant Serplulimab in Combination With...
Show More Location
Tianjin Medical University Cancer Institute & Hospital
Learn More & Join Trial
Adjuvant Treatment With Serplulimab,Trastuzumab and SOX in the HER-2 Positive GC/GEJC PHASE2 This is a prospective, single arm, multicenter phase II study to assess the...
Show More Location
Multiple Locations
Learn More & Join Trial
HIPEC Priming Followed by Serplulimab Plus SOX/XELOX in Locally Advanced Gastric Cancer PHASE2 Patients with locally advanced gastric cancer (LAGC), particularly those wi...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety of Minimally Invasive D2+PAND Gastrectomy for Gastric Cancer With PAN Metastasis After Conversion Immunochemotherapy NA This is a prospective, open-label, single-center, Phase II clinical trial. ...
Show More Location
First Affiliated Hospital of Nanjing Medical Unviersity
Learn More & Join Trial
Megestrol Acetate Oral Suspension for Cachexia in Patients With cStage III Gastric/Gastroesophageal Junction Adenocarcinoma Receiving Neoadjuvant Therapy With Serplulimab Combined With SOX PHASE2 This study is an open-label, prospective, randomized controlled phase II cl...
Show More Location
First Affiliated Hospital of Nanjing Medical Unviersity
Learn More & Join Trial
Perioperative Chemotherapy Combined With Serplulimab or Placebo for pMMR Locally Advanced Gastric Adenocarcinoma (FOCUS-05) PHASE2 This phase II study is a prospective, multi-center, double-blinded, and ran...
Show More Location
The First Affiliated Hospital, College of Medicine, Zhejiang University
Learn More & Join Trial
Neoadjuvant PD-1 Inhibitor Plus SOX Chemotherapy With or Without Short-Course Radiotherapy for Locally Advanced Upper Gastric or GEJ Adenocarcinoma NA This study is a prospective, open-label, multicenter, randomized controlled...
Show More Location
Tongji Hospital, Huazhong University of Science and Technology
Learn More & Join Trial
Perioperative HLX10 (Serplulimab) With S-1+Oxaliplatin (SOX) in Locally Advanced and PD-L1-Positive Gastric or Esophagogastric Junction Adenocarcinoma PHASE2 To evaluate the clinical efficacy of perioperative treatment with S-1 + oxa...
Show More Location
Chiba Cancer Center
Learn More & Join Trial
Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction PHASE2 This is a multicenter, double-blind, randomized, phase 2 trial to investiga...
Show More Location
The fourth hospital of Hebei Medical University
Learn More & Join Trial